Cannara Biotech Stock Probability of Future Stock Price Finishing Under 0.78
| LOVE Stock | CAD 0.70 0.02 2.78% |
Cannara |
Cannara Biotech Target Price Odds to finish below 0.78
The tendency of Cannara Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under C$ 0.78 after 90 days |
| 0.70 | 90 days | 0.78 | under 95 |
Based on a normal probability distribution, the odds of Cannara Biotech to stay under C$ 0.78 after 90 days from now is under 95 (This Cannara Biotech probability density function shows the probability of Cannara Stock to fall within a particular range of prices over 90 days) . Probability of Cannara Biotech price to stay between its current price of C$ 0.70 and C$ 0.78 at the end of the 90-day period is about 31.89 .
Assuming the 90 days trading horizon Cannara Biotech has a beta of 0.3. This indicates as returns on the market go up, Cannara Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cannara Biotech will be expected to be much smaller as well. Additionally Cannara Biotech has an alpha of 0.3486, implying that it can generate a 0.35 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Cannara Biotech Price Density |
| Price |
Predictive Modules for Cannara Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cannara Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cannara Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cannara Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cannara Biotech is not an exception. The market had few large corrections towards the Cannara Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cannara Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cannara Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.35 | |
β | Beta against Dow Jones | 0.30 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | 0.05 |
Cannara Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cannara Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cannara Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cannara Biotech had very high historical volatility over the last 90 days | |
| Cannara Biotech has some characteristics of a very speculative penny stock | |
| Cannara Biotech is unlikely to experience financial distress in the next 2 years | |
| About 49.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024 - Yahoo Finance |
Cannara Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cannara Stock often depends not only on the future outlook of the current and potential Cannara Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cannara Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 90.3 M |
Cannara Biotech Technical Analysis
Cannara Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Cannara Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cannara Biotech. In general, you should focus on analyzing Cannara Stock price patterns and their correlations with different microeconomic environments and drivers.
Cannara Biotech Predictive Forecast Models
Cannara Biotech's time-series forecasting models is one of many Cannara Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cannara Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cannara Biotech
Checking the ongoing alerts about Cannara Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cannara Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cannara Biotech had very high historical volatility over the last 90 days | |
| Cannara Biotech has some characteristics of a very speculative penny stock | |
| Cannara Biotech is unlikely to experience financial distress in the next 2 years | |
| About 49.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024 - Yahoo Finance |
Additional Tools for Cannara Stock Analysis
When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.